Home
Company Info
Company Evolution
Company Profile
Management Team
Business Strategy
Corporate Governance
Media Centre
Events
Media Contact
Investor Relations
Investor Home
Press Release Archive
Company Facts Report
Broker Forecasts
Email Alerts
Trading Info
Annual & Interim Reports
Advisers & Registrars
Company Presentations
Financial Calendar
Shareholder FAQs
Contact Details
Research & Development
Preclinical Research
Selected Publications
Research Programmes
Product Portfolio
Commercialisation
Commercialisation Overview
Outlicensing
Contact Us
Glossary
Navigation menu
Discover more about Ark Therapeutics products here
Ark Therapeutics, From science To patients
Ark commences contract manufacture for Lx Therapies VEGF-C gene medicine programme
01 July 2009
Ark announces major advance in adenoviral gene-based medicine production
24 June 2009
Ark and AOTI sign international medical device sales collaboration on KerrabootŪ
17 June 2009
Read more news stories here
2009 Interim Management Statement published
18 May 2009
2008 Annual Report published
18 March 2009
2008 Interim Report published
27 August 2008
Visit the Investor Relations section of the web site.
2008 Preliminary Results Presentation
11 March 2009
44.00 p
Change: 0.00p
Last Trade: 3/7/2009 23:36
View share price data
Use the search form below to search our site.
Search
Download the latest Annual Report & Accounts
[1.82MB]
Keep up-to-date with product developments, investor relations information and news with our email updates.
Register here to receive our email alerts.
©2009 Ark Therapeutics Group plc. All rights reserved | Site Design and Maintenance by
3wise Internet Solutions
To view PDF files on this site, you will need Adobe Acrobat Reader.
Download it for free here.
Stats Script
Stats Script